Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Velcade
Active Ingredient: Bortezomib 3.5mg
Dosage Form: Powder for injection
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Dated this 26th day of October 2006.
KAREN MITCHELL, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).